Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Infectious Diseases

• Publication date

  2012-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/infdis/jis405PMID 22815381
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A repeated survey of sexual behavior among female university students in Sweden

  2012cited by this paper
• Awareness and knowledge of human papillomavirus in the Swedish adult population.

  2012cited by this paper
• The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme

  2011cited by this paper
• External review and validation of the Swedish national inpatient register

  2011influential reference
• Population effectiveness, not efficacy, should decide who gets vaccinated against human papillomavirus via publicly funded programs.

  2011cited by this paper
• Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.

  2011cited by this paper
• HPV Vaccine Acceptability in Heterosexual, Gay, and Bisexual Men

  2011cited by this paper
• Genital warts and cost of care in England

  2011cited by this paper
• Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity.

  2010cited by this paper
• Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

  2010cited by this paper
• Incidence of anogenital warts in Germany: a population-based cohort study

  2010cited by this paper
• Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women

  2009cited by this paper
• Increase in reported gonorrhoea cases in Sweden, 2001 - 2008.

  2009cited by this paper
• Sexual risk-taking in the general population of Sweden (1989-2007).

  2009cited by this paper
• Introduction of human papillomavirus (HPV) vaccination in Sweden.

  2009cited by this paper
• The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research

  2009cited by this paper
• Modern Management of External Genital Warts

  2008cited by this paper
• Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination.

  2008cited by this paper
• Human papillomavirus type-distribution in condylomata acuminata of mainland China: a meta-analysis

  2008cited by this paper
• The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries.

  2007cited by this paper
• Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.

  2006cited by this paper
• Cancer risk among patients with condylomata acuminata

  2006cited by this paper
• Rate and Predictors of New Genital Warts Claims and Genital Warts-Related Healthcare Utilization Among Privately Insured Patients in the United States

  2004cited by this paper
• THE LIVED EXPERIENCE OF GENITAL WARTS: THE SWEDISH EXAMPLE

  2004cited by this paper
• Imiquimod to Treat Different Cancers of the Epidermis

  2003cited by this paper
• Symptomatic genital papillomavirus infection in a community

  1996cited by this paper
• Extended Report

  year unknowncited by this paper

• Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV‐related disease and harms from vaccination

  2025cites this paper
• Should routine HPV vaccination programs include males 25–29 years? A systematic review and global meta-analysis

  2025cites this paper
• Population-Level Impact of Human Papillomavirus Vaccination on the Incidence of Genital Warts in Sweden

  2025cites this paper
• Reducing HPV-associated oropharyngeal cancer risk and exploring the role of safe sexual activity and behavioral modifications

  2024cites this paper
• The Burden of Genital Warts in Finland: Cross-Sectional Analysis of the Prevalence and Direct Medical Costs in 2018

  2023cites this paper
• Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada

  2022cites this paper
• Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France

  2022cites this paper
• Diagnostic Trends and Prescription Patterns in Disruptive Mood Dysregulation Disorder and Bipolar Disorder.

  2021cites this paper
• Real-world impact and effectiveness assessment of the quadrivalent HPV vaccine: a systematic review of study designs and data sources

  2021cites this paper
• Cost-Effectiveness of Vaccination and the Value of Prevention

  2020cites this paper
• Impact of a single-age cohort human papillomavirus vaccination strategy in Catalonia, Spain: Population-based analysis of anogenital warts in men and women.

  2020cites this paper
• POPULATION-LEVEL IMPACT AND HERD EFFECTS FOLLOWING THE INTRODUCTION OF HUMAN

  2019cites this paper
• The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity.

  2019cites this paper
• Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.

  2019cites this paper
• Comment améliorer la couverture vaccinale du papillomavirus humain : propositions des médecins généralistes des Pyrénées-Atlantiques à partir de l'analyse de leur pratique

  2019cites this paper
• Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions.

  2018cites this paper
• The early impact of human papillomavirus vaccination on anogenital warts in Québec, Canada

  2018cites this paper
• Human papillomavirus vaccination and the role of herd effects in future cancer control planning: a review

  2018cites this paper
• Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden.

  2018cites this paper
• Trends in the Prevalence of Anogenital Warts Among Patients at Sexually Transmitted Disease Clinics-Sexually Transmitted Disease Surveillance Network, United States, 2010-2016.

  2018cites this paper
• A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries

  2018cites this paper
• Cost-effectiveness of sex-neutral HPV-vaccination in Sweden, accounting for herd-immunity and sexual behaviour.

  2018cites this paper
• Current guidelines may not be the best for follow‐up of abnormal Pap smear results

  2018cites this paper
• Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine—an interrupted time series analysis from 2005 to 2010 using health insurance data

  2017cites this paper
• Impact of Number of Human Papillomavirus Vaccine Doses on Genital Warts Diagnoses Among a National Cohort of U.S. Adolescents

  2017cites this paper
• Lessons learned from domestic and international human papillomavirus vaccination programs: a review

  2017cites this paper
• Human papilloma virusvaccination of boys in the Swedish national vaccination programme

  2017influential citation
• Effectiveness and equity of cervical cancer prevention : real-life evidence from organised programmes in Sweden

  2017cites this paper
• Health economic evaluation of universal HPV vaccination within the Swedish national vaccination programme for children

  2017cites this paper
• Early Evidence of the Effectiveness of the Human Papillomavirus Vaccination Program Against Anogenital Warts in Manitoba, Canada: A Registry Cohort Study

  2017cites this paper
• Incidence of anogenital warts in Liuzhou, south China: a comparison of data from a prospective study and from the national surveillance system

  2017cites this paper
• Preventive Care in Women's Health.

  2016cites this paper
• Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment.

  2016cites this paper
• Human Papillomavirus Vaccination and Cervical Cytology Outcomes Among Urban Low-Income Minority Females.

  2016cites this paper
• Vaccination HPV dans la vraie vie : dix années d’expérience

  2016cites this paper
• Sexually transmitted infections after bereavement – a population-based cohort study

  2016cites this paper
• Register-based evaluation of HPV vaccination programs

  2016cites this paper
• Monitoring the impact of HPV vaccine in males—Considerations and challenges

  2016cites this paper
• Interventions to increase HPV vaccination coverage: A systematic review

  2016cites this paper
• Impact populationnel de la vaccination contre les virus du papillome humain : revue systématique et synthèse des prédictions de 16 modèles mathématiques dynamiques

  2016cites this paper
• Impact of HPV vaccination on anogenital warts and respiratory papillomatosis

  2016cites this paper
• Evaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan Africa

  2015cites this paper
• Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

  2015cites this paper
• ffectiveness of a provider-focused intervention to improve HPV accination rates in boys and girls

  2015cites this paper
• Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination

  2015cites this paper
• A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

  2015cites this paper
• Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls.

  2015cites this paper
• Immunogenicity and safety of the 9-valent HPV vaccine in men.

  2015cites this paper
• Immunogenicity and Safety of a 9-Valent HPV Vaccine

  2015cites this paper
• Oral human papillomavirus (HPV) prevalence in youth and cervical HPV prevalence in women attending a youth clinic in Sweden, a follow up-study 2013–2014 after gradual introduction of public HPV vaccination

  2015cites this paper
• A cost‐effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer

  2015cites this paper
• Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data.

  2015cites this paper
• A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9–15-Year-Old Girls

  2015cites this paper
• Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma?

  2015cites this paper
• Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004–2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination

  2015cites this paper
• Present status of human papillomavirus vaccine development and implementation.

  2015cites this paper
• 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV

  2015cites this paper
• An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015

  2015cites this paper
• An Open-Label, Randomized Study of a 9-Valent Human Papillomavirus Vaccine Given Concomitantly with Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccines to Healthy Adolescents 11–15 Years of Age

  2015cites this paper
• Trends in cervical intraepithelial neoplasia Grade 2+ after human papillomavirus vaccination: The devil is in the details

  2015cites this paper
• Early Direct and Indirect Impact of Quadrivalent HPV (4HPV) Vaccine on Genital Warts: a Systematic Review

  2015cites this paper
• Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study

  2015cites this paper
• HPV prophylactic vaccines: lessons learned from 10 years experience

  2015cites this paper
• Données et outils pour l'optimisation de l’impact de la vaccination prophylactique contre les papillomavirus humains en France

  2015cites this paper
• Potential impact of the human papillomavirus vaccine on the incidence proportion of genital warts in French women (EFFICAE study): a multicentric prospective observational study.

  2015cites this paper
• Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: Results from a longitudinal Dutch cohort study.

  2015cites this paper
• Criminal offending as part of an alternative reproductive strategy: investigating evolutionary hypotheses using Swedish total population data

  2014cites this paper
• Barnmorskors arbete med cervixcancerprevention på ungdomsmottagningar

  2014cites this paper
• Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease

  2014cites this paper
• prescription data from New Zealand vaccination programme: national Evidence for effectiveness of a national HPV

  2014cites this paper
• Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a review

  2014cites this paper
• Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program

  2014cites this paper
• GENITAL WARTS INCIDENCE IN SAINT-PETERBURG, LENINGRADSKAYA REGION, KARELIYA REPUBLIC IN 2004–2013

  2014cites this paper
• Human papillomavirus DNA in men who have sex with men: type-specific prevalence, risk factors and implications for vaccination strategies

  2014cites this paper
• Early impact of human papillomavirus vaccination on cervical neoplasia--nationwide follow-up of young Danish women.

  2014cites this paper
• HPV vaccines to prevent cervical cancer and genital warts: an update.

  2014cites this paper
• Prevalence of Genital Warts Among Sexually Transmitted Disease Clinic Patients—Sexually Transmitted Disease Surveillance Network, United States, January 2010 to December 2011

  2014cites this paper
• Impact of HPV immunization on the detection of cervical disease

  2014cites this paper
• A reduced national incidence of anogenital warts in young Danish men and women after introduction of a national quadrivalent human papillomavirus vaccination programme for young women--an ecological study.

  2014cites this paper
• Qualitative study of the feasibility of HPV vaccine delivery to young adolescent girls in Vietnam: evidence from a government-implemented demonstration program

  2014cites this paper
• Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program

  2014cites this paper
• Long-term Study of a Quadrivalent Human Papillomavirus Vaccine

  2014cites this paper
• Genital warts.

  2014cites this paper
• Postlicensure monitoring of HPV vaccination programmes.

  2014cites this paper
• [Cancer of cervix in Chile. Too much vaccine amid a neglected Papanicolau].

  2014cites this paper
• Evidence for effectiveness of a national HPV vaccination programme: national prescription data from New Zealand

  2014cites this paper
• Population impact of HPV vaccines: summary of early evidence.

  2013cites this paper
• Attitudes Toward HPV Vaccination Among Low-Income and Minority Parents of Sons

  2013cites this paper
• The changing landscape of controlling sexually transmitted infections in the U.S. military.

  2013cites this paper
• Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data

  2013cites this paper
• Trust versus concerns—how parents reason when they accept HPV vaccination for their young daughter

  2013cites this paper
• Declining Rates of High-Grade Cervical Lesions in Young Women in Connecticut, 2008–2011

  2013cites this paper
• Evaluating human papillomavirus vaccination programs.

  2013cites this paper
• Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study

  2013cites this paper
• Comprehensive attention to partners of men with condyloma acuminatum and the early diagnosis of cervical cancer

  2013cites this paper
• Relation between condylomata acuminata and penis cancer and anus cancer

  2013cites this paper
• on the treatment of genital

  2013cites this paper
• HPV related diseases in males: a heavy vaccine-preventable burden

  2013cites this paper
• Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination.

  2013cites this paper
• Incidence of genital warts among U.S. service members before and after the introduction of the quadrivalent human papillomavirus vaccine.

  2013cites this paper